Peisheng Xu

ORCID: 0000-0002-4486-7058
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • RNA Interference and Gene Delivery
  • Nanoplatforms for cancer theranostics
  • MicroRNA in disease regulation
  • Graphene and Nanomaterials Applications
  • Advanced biosensing and bioanalysis techniques
  • Circular RNAs in diseases
  • Virus-based gene therapy research
  • Advanced Nanomaterials in Catalysis
  • Autophagy in Disease and Therapy
  • Dendrimers and Hyperbranched Polymers
  • Cancer-related molecular mechanisms research
  • Polymer Surface Interaction Studies
  • dental development and anomalies
  • Cancer-related gene regulation
  • Photodynamic Therapy Research Studies
  • Cancer Research and Treatments
  • Hydrogen's biological and therapeutic effects
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Wnt/β-catenin signaling in development and cancer
  • Nanocluster Synthesis and Applications
  • Nanopore and Nanochannel Transport Studies
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Microfluidic and Capillary Electrophoresis Applications

University of South Carolina Sumter
2012-2024

University of South Carolina
2012-2023

Shengli Oilfield Central Hospital
2021

Jinan University
2019-2021

Columbia College - South Carolina
2014

Purdue University West Lafayette
2008-2013

University of Wyoming
2004-2010

Stomatology Hospital
2009-2010

Chongqing Medical University
2009

Sichuan University
2009

Reversing the charges: Targeted charge-reversal nanoparticles (TCRNs) comprised of poly(ε-caprolactone)-block-polyethyleneimine (PCL-PEI), whose amine groups are converted into amides, negatively charged at neutral pH but become positively pH<6 (see picture). TCRNs effectively enter cells, regenerate PEI layer in lysosomes, and localize nucleus for nuclear drug delivery. Supporting information this article is available on WWW under http://www.wiley-vch.de/contents/jc_2002/2007/z605254_s.pdf...

10.1002/anie.200605254 article EN Angewandte Chemie International Edition 2007-05-25

We reexamined the cellular drug delivery mechanism by poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) to determine their utility and limitations as an intracellular system. First, we prepared PLGA NPs which physically encapsulated Nile red (a hydrophobic fluorescent dye), in accordance with usual procedure for labeling NPs, incubated them mesothelial cells, observed increase fluorescence. then from chemically conjugated a dye uptake cells using confocal microscopy. also used coherent...

10.1021/mp800137z article EN Molecular Pharmaceutics 2008-11-26

The objective of these investigations was to test the hypothesis that a rapid cytoplasmic release profile from nanoparticles would potentiate anticancer activity cisplatin. Cisplatin-loaded with pH-responsive poly[2-(N,N-diethylamino)ethyl methacrylate] (PDEA) cores were synthesized PDEA-block-poly(ethylene glycol) (PDEA−PEG) copolymer by using solvent-displacement (acetone−water) method. Nanoparticles pH-nonresponsive poly(ε-caprolactone) (PCL) made PCL-block-PEG (PCL−PEG) used for...

10.1021/bm050902y article EN Biomacromolecules 2006-02-15

Abstract Diabetic cardiomyopathy is manifested by compromised systolic and diastolic function. This study was designed to examine the role of advanced glycation endproduct (AGE) AGE receptor (RAGE) in diabetic cardiomyopathy. Heart function assessed isolated control streptozotocin‐induced hearts following vivo RAGE gene knockdown using RNA interference. Cardiomyocyte mechanical properties were evaluated including peak shortening (PS), time‐to‐PS (TPS) time‐to‐90% relengthening (TR 90 )....

10.1111/j.1582-4934.2008.00547.x article EN other-oa Journal of Cellular and Molecular Medicine 2008-10-13

To mimic the clinic dosing pattern, initially administering high loading dose and then low maintenance dose, we designed a novel poly(2-(pyridin-2-yldisulfanyl)ethyl acrylate) (PDS) based nanoparticle delivery system. Side chain functional PDS was synthesized by free radical polymerization. Polyethylene glycol cyclo(Arg-Gly-Asp-d-Phe-Cys) (cRGD) peptide conjugated to through thiol-disulfide exchange reaction achieve RPDSG polymer. RPDSG/DOX, loaded with doxorubicin, fabricated cosolvent...

10.1021/mp300274g article EN Molecular Pharmaceutics 2012-08-09

Our previous studies demonstrated that the natural compound emodin blocks tumor-promoting feedforward interactions between cancer cells and macrophages, thus ameliorates immunosuppressive state of tumor microenvironment. Since tumor-associated macrophages (TAMs) also affect epithelial mesenchymal-transition (EMT) stem cell (CSC) formation, here we aimed to test if as a neoadjuvant therapy halts breast metastasis by attenuating TAM-induced EMT CSC formation cells. Methods: Bioinformatical...

10.7150/thno.45395 article EN Theranostics 2020-01-01

"Stealth" nanoparticles made from polymer micelles have been widely explored as drug carriers for targeted delivery. High stability (i.e., low critical micelle concentration (CMC)) is required their intravenous applications. Herein, we present a "core−surface cross-linking" concept to greatly enhance nanoparticle's stability: amphiphilic brush copolymers form core−surface cross-linked (nanoparticles) (SCNs). The consisted of hydrophobic poly(ε-caprolactone) (PCL) and hydrophilic...

10.1021/bm049874u article EN Biomacromolecules 2004-07-21

1. Cisplatin is a potent chemotherapeutic agent with broad-spectrum antineoplastic activity against various types of tumours. However, major factor limiting treatment cisplatin its acute and cumulative cardiotoxicity. The aim the present study was to explore effect on myocardial contractile function possible underlying cellular mechanisms. 2. C57 mice were treated (10 mg/kg per day, i.v.) or vehicle (0.9% NaCl) for 1 week assessed using Langendorff cardiomyocyte edge-detection systems....

10.1111/j.1440-1681.2009.05323.x article EN Clinical and Experimental Pharmacology and Physiology 2009-10-29

Zwitterionic chitosan, a chitosan derivative with unique pH-dependent charge profile, was employed to create stealth coating on the cationic surface of drug carriers. chitosans were synthesized by amidation succinic anhydride. The anhydride-conjugated had an isoelectric point, which could be easily tuned from pH 4.9 7.1 and showed opposite charges below above point. able inhibit protein adsorption at physiological pH, compatible blood components well tolerated upon intraperitoneal injection....

10.1021/bm100481r article EN Biomacromolecules 2010-08-10

Polyamidoamine (PAMAM) dendrimers with primary amine termini have been extensively explored as drug and gene carriers owing to their unique properties, but amine-carried cationic charges cause nonspecific cellular uptakes, systemic toxicity other severe problems in vivo applications.In this article, we report a charge-reversal approach that latently deactivates PAMAM's amines negatively charged acid-labile amides order inhibit its interaction cells, regenerates the active PAMAM once acidic...

10.2217/nnm.10.86 article EN Nanomedicine 2010-10-01

Droplet microfluidics provides a high-throughput platform for screening subjects and conditions involved in biology. Droplets with encapsulated beads cells have been increasingly used studying molecular cellular sorting is needed to isolate analyze the subject of interest during such screening. The vast majority current techniques use fluorescence intensity emitted by each droplet as only criterion. However, due randomness imperfections encapsulation process, typically mixed population...

10.1039/c2lc40950j article EN Lab on a Chip 2012-10-19

A nano cocktail, NCPD, fabricated from a pH and redox dual responsive polymer shows multicompartment structure. The NCPD nanogel is stable in physiological environments while intracellular spontaneous swelling fast releasing its payload. displays much stronger synergism than free drug counterpart, which suggests that could greatly attenuate the side effects of cocktails boosting synergistic anticancer effects. Detailed facts importance to specialist readers are published as "Supporting...

10.1002/adma.201202687 article EN Advanced Materials 2012-09-24

A gold/mesoporous silica hybrid nanoparticle (GoMe), which possesses the best of both conventional gold nanoparticles and mesoporous nanoparticles, such as excellent photothermal converting ability well high drug loading capacity triggerable release, has been developed. In contrast to nanorod other heat generating GoMe is stable can be repetitively activated through NIR irradiation. Doxorubicin loaded (DOX@GoMe) sensitive irradiation intracellularly elevated redox potential. DOX@GoMe coupled...

10.1166/jbn.2016.2195 article EN Journal of Biomedical Nanotechnology 2016-01-20

It is postulated that the complexity and heterogeneity in cancer may hinder most efforts target a single pathway. Thus, discovery of novel therapeutic agents targeting multiple pathways, such as miRNAs, holds promise for future therapy. One miRNA, miR-489, downregulated majority breast cells several drug-resistant cell lines, but its role underlying mechanism tumor suppression drug resistance needs further investigation. The current study identifies autophagy pathway targeted by miR-489...

10.1158/1541-7786.mcr-17-0634 article EN Molecular Cancer Research 2018-05-21

Abstract Photothermal therapy (PTT) has attracted tremendous attention due to its noninvasiveness and localized treatment advantages. However, heat shock proteins (HSPs) associated self‐preservation mechanisms bestow cancer cells thermoresistance protect them from the damage of PTT. To minimize improve efficacy PTT, an integrated on‐demand nanoplatform composed a photothermal conversion core (gold nanorod, GNR), cargo HSPs inhibitor (triptolide, TPL), mesoporous silica based nanoreservoir,...

10.1002/smll.202003398 article EN Small 2020-08-14

Abstract The biomimetic enzyme activity of cerium oxide nanoparticles (CeNPs) prefers ultrasmall particle size and bare surface. Unfortunately, those two features are not favorable for its in vivo application due to easy aggregation fast renal filtration. To take advantage the CeNP cancer therapy, a homologous targeted nanoparticle system, (T‐CeNP), with integration biodegradable dendritic mesoporous silica nanoparticle, superoxide dismutase catalase mimicking CeNPs, camouflage coating cell...

10.1002/adfm.202100262 article EN Advanced Functional Materials 2021-03-29

Abstract Polymer nanoparticles are extensively explored as drug carriers but they generally have issues of premature burst release, slow cellular uptake, and retention in acidic intracellular compartments. Herein, we report multifunctioning three‐layered (3LNPs) that can overcome these problems. The 3LNPs a poly(ε‐caprolactone) (PCL) core, pH‐responsive poly[2‐(N,N‐diethylamino)ethyl methacrylate](PDEA) middle layer polyethylene glycol (PEG) outer layer. PDEA is insoluble at pH above 7...

10.1002/aic.11600 article EN AIChE Journal 2008-09-23

// Yogin Patel 1, 2, * , Nirav Shah Ji Shin Lee 3 Eleni Markoutsa 4 Chunfa Jie 5 Shou Liu 2 Rachel Botbyl David Reisman Peisheng Xu Hexin Chen 1 Department of Biological Science, University South Carolina, Columbia, SC, USA Center for Colon Cancer Research, Surgery, Chonnam National University, Gwangju, Republic Korea Drug Discovery and Biomedical Sciences, Carolina College Pharmacy, Master Science in Sciences Program, Des Moines Moines, IA, These authors have contributed equally to this...

10.18632/oncotarget.7577 article EN Oncotarget 2016-02-22

Ideal "smart" nanoparticles for drug delivery should enhance therapeutic efficacy without introducing side effects. To achieve that, we developed a system (HCN) based on polymer-drug conjugate of poly[2-(pyridin-2-yldisulfanyl)]-graft-poly(ethylene glycol) and camptothecin with an intracellularly cleavable linker human epidermal growth factor receptor 2 (HER2) targeting ligands. An in vitro release study found that HCN was stable the physiological environment supersensitive to stimulus...

10.1021/mp5000482 article EN publisher-specific-oa Molecular Pharmaceutics 2014-04-29
Coming Soon ...